Trial
NCT05647447
Pilot of Osanetant to Reduce Severity of Hot Flashes in Men With Adenocarcinoma of the Prostate
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Kansas Medical Center
Collaborators
—
Condition
Prostate Adenocarcinoma
Intervention
Osanetant
Why stopped
Development of the drug program has been discontinued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-21